why choose us

First received: November 08, 2022

Clinical Trial: Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Study of Darolutamide and Abemaciclib in High-Risk Prostate Cancer

Brief Summary: This research study is trying to determine the safety and efficacy of the combination of two oral drugs, abemaciclib and darolutamide, with androgen deprivation therapy (ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a recommended dose for the second phase.The names of the study drugs and interventions involved in this study are:* Darolutamide* Abemaciclib* Androgen deprivation therapy (ADT) - this includes several different…

Read more